Circle Secures Massive Blockchain Patent Portfolio from IBM to Supercharge USDC and Arc
Circle buys nearly 1,000 blockchain patents from IBM, becoming the top U.S. holder.
Already have an account? Sign in.
Circle buys nearly 1,000 blockchain patents from IBM, becoming the top U.S. holder.
AstraZeneca’s Ultomiris Phase 3 miss in adult HSCT-TMA is a clear positive for Omeros’ Yartemlea, removing a key rival.
Wells Fargo sees a booming psychedelic depression market, with new treatments challenging Spravato and creating big opportunities for biotech firms.
Piper Sandler upgrades Rivian to Overweight with a $20 target, citing smooth R2 launch, stronger demand, and a de-risked balance sheet.